Abstract
The present study was carried out to examine the mechanisms of the synergistic interaction of PAF and A23187 mediated platelet aggregation. We found that platelet aggregation mediated by subthreshold concentrations of PAF (5 nM) and A23187 (1 µM) was inhibited by PAF receptor blocker (WEB 2086, IC50=0.65 µM) and calcium channel blockers, diltiazem (IC50=13 µM) and verapamil (IC50=18 µM). Pretreatment of platelets with PAF and A23187 induced rise in intracellular calcium and this effect was also blocked by verapamil. While examining the role of the down stream signaling pathways, we found that platelet aggregation induced by the co-addition of PAF and A23187 was also inhibited by low concentrations of phospholipase C (PLC) inhibitor (U73122; IC50 = 10 µM), a cyclooxygenase inhibitor (indomethacin; IC50=0.2 µM) and inhibitor of TLCK, herbimycin A with IC50 value of 5 µM. The effect was also inhibited by a specific TXA2 receptor antagonist, SQ 29548 with very low IC50 value of 0.05 µM. However, the inhibitors of MAP kinase, PD98059 and protein kinase C, chelerythrine had no effect on PAF and A23187-induced platelet aggregation. These data suggest that the synergism between PAF and A23187 in platelet aggregation involves activation of thromboxane and tyrosine kinase pathways.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Rasheed, H., Saeed, S. Involvement of thromboxane A2 and tyrosine kinase in the synergistic interaction of platelet activating factor and calcium ionophore A23187 in human platelet aggregation. Exp Mol Med 36, 220–225 (2004). https://doi.org/10.1038/emm.2004.30
Published:
Issue Date:
DOI: https://doi.org/10.1038/emm.2004.30
Keywords
This article is cited by
-
Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise
American Journal of Cardiovascular Drugs (2019)
-
Melanoma cell metastasis via P-selectin-mediated activation of acid sphingomyelinase in platelets
Clinical & Experimental Metastasis (2017)
-
Investigation of piperidine derivatives in ex vivo models of pain and platelet aggregation
Archives of Pharmacal Research (2012)
-
Ion transport regulated by protease‐activated receptor 2 in human airway Calu‐3 epithelia
British Journal of Pharmacology (2005)